disease-modifying antirheumatic drug , DMARDs (Abkürzung)

All patients in the group were receiving disease-modifying antirheumatic drugs and were clinically stable.

Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.

Most patients begin treatment with a DMARD (disease-modifying antirheumatic drug).

Some disease-modifying antirheumatic drugs (DMARDs) that have been around for decades.

It is known as a disease-modifying antirheumatic drug (DMARD).

Disease-modifying antirheumatic drugs (DMARDs) are usually started within 3 months of your diagnosis.

Disease-modifying antirheumatic drugs (DMARDs) slow or halt the progress of the disease.

Antimalarials are used either alone or in combination with other disease-modifying antirheumatic drugs (DMARDs).

To protect joints from damage, doctors turn to disease-modifying antirheumatic drugs (DMARDs).

It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs).

For many patients, the pain and joint destruction the disease causes can be managed with medications such as disease-modifying antirheumatic drugs, anti-inflammatory drugs, and steroids.

Also, disease-modifying antirheumatic drugs (DMARDs) such as methotrexate may be helpful.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Cyclophosphamide is a disease-modifying antirheumatic drug (DMARD), which means it controls the progression of the disease.

Biologics - and other disease-modifying antirheumatic drugs (DMARDs) - have revolutionized the approach.

Medicines called disease-modifying antirheumatic drugs (DMARDs) can slow or sometimes prevent joint destruction.

Discussion Currently, MTX is the most widely used disease-modifying antirheumatic drug for the treatment of RA.

Methotrexate and etanercept are disease-modifying antirheumatic drugs (DMARDs).

Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, which can help relieve joint pain and dry skin.

Disease-modifying antirheumatic drugs (DMARD) are the primary treatment for RA.

Gold is not usually the first treatment given to people with rheumatoid arthritis, since methotrexate and other disease-modifying antirheumatic drugs (DMARDs) are available.

That requires a more powerful disease-modifying antirheumatic drug (DMARD) or biologic response modifier, or both.

Disease-modifying antirheumatic drugs (DMARDs) help slow or stop progression of RA.

These drugs are called disease-modifying antirheumatic drugs (DMARDs), and they are an important part of an overall treatment plan.

Sometimes disease-modifying antirheumatic drugs (DMARDs) can reduce the size of RA nodules.